Works matching IS 01926233 AND DT 2014 AND VI 42 AND IP 3


Results: 14
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Dose-related Differences in the Pharmacodynamic and Toxicologic Response to a Novel Hyperglycosylated Analog of Recombinant Human Erythropoietin in Sprague-Dawley Rats with Similarly High Hematocrit.

    Published in:
    Toxicologic Pathology, 2014, v. 42, n. 3, p. 524, doi. 10.1177/0192623313486319
    By:
    • Andrews, Dina A.;
    • Boren, Babette M.;
    • Turk, James R.;
    • Boyce, Rogely W.;
    • He, Yudong D.;
    • Hamadeh, Hisham K.;
    • Mytych, Daniel T.;
    • Barger, Troy E.;
    • Salimi-Moosavi, Hossein;
    • Sloey, Bethlyn;
    • Elliott, Steve;
    • McElroy, Patricia;
    • Sinclair, Angus M.;
    • Shimamoto, Grant;
    • Pyrah, Ian T. G.;
    • Lightfoot-Dunn, Ruth M.
    Publication type:
    Article
    13

    Cytokines Associated with Increased Erythropoiesis in Sprague-Dawley Rats Administered a Novel Hyperglycosylated Analog of Recombinant Human Erythropoietin.

    Published in:
    Toxicologic Pathology, 2014, v. 42, n. 3, p. 540, doi. 10.1177/0192623313486318
    By:
    • Andrews, Dina A.;
    • Hamadeh, Hisham K.;
    • He, Yudong D.;
    • Boren, Babette M.;
    • Turk, James R.;
    • Boyce, Rogely W.;
    • Mytych, Daniel T.;
    • Barger, Troy E.;
    • Salimi-Moosavi, Hossein;
    • Sloey, Bethlyn;
    • Elliott, Steve;
    • McElroy, Patricia;
    • Sinclair, Angus M.;
    • Shimamoto, Grant;
    • Pyrah, Ian T. G.;
    • Lightfoot-Dunn, Ruth M.
    Publication type:
    Article
    14